連絡先
ペプチドのランドスケープを形成するすべての人々と組織 — 科学を発表する研究者、治療法を適用する臨床医、影響力を拡大するインフルエンサー、そして製薬会社が市場に投入するもの。
ペプチドの議論を形成するポッドキャスター、バイオハッカー、コンテンツクリエイター
基礎的なペプチド科学を発表する科学者と学術者
ペプチド療法を使用する医師や実践者
FDA認可のペプチドベースの薬物を開発し、製造している企業
特集

Andrew Huberman is an associate professor of neurobiology and ophthalmology at Stanford University, known for his popular science podcast 'Huberman Lab'. He has a background in psychology and neuroscience and explores various topics related to health, learning, and behavior.

Ben Greenfield is a triathlete, personal trainer, and biohacking influencer known for his work in nutrition and health optimization.

Bryan Johnson is an American entrepreneur and venture capitalist, known for founding Kernel and Braintree. He focuses on brain technology and anti-aging initiatives.
Derek MPMD is an influencer in the peptide, longevity, and biohacking sectors, known for discussing various health markers and peptides that can influence bodily functions.
Eli Lilly was an American businessman who founded Eli Lilly and Company, a pharmaceutical company known for developing medications including tirzepatide and dulaglutide.

Novo Nordisk is a Danish pharmaceutical company focused on diabetes and obesity treatments, known for products like semaglutide and liraglutide.

Peter Attia is a Canadian-American author and former researcher known for his work in longevity medicine, particularly through the lens of nutrition, exercise, and biochemistry.
Predrag Sikiric is a researcher focusing on the therapeutic applications of peptides, particularly BPC-157.